Stay updated on ONC201 + Nivolumab in MSS mCRC Clinical Trial
Sign up to get notified when there's something new on the ONC201 + Nivolumab in MSS mCRC Clinical Trial page.

Latest updates to the ONC201 + Nivolumab in MSS mCRC Clinical Trial page
- ChecktodayChange DetectedRevision: v3.3.4 added; Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedLocations now includes Rhode Island and the page revision is updated to v3.3.3; the separate 'Rhode Island Locations' entry and the HHS Vulnerability Disclosure link appear to have been removed.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page revision label updated from Revision: v3.2.0 to Revision: v3.3.2, indicating a minor update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedNotice about government funding lapse and potential operating status updates was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedThe two screenshots show the same study page with minor visual differences only, and there are no changes to core trial details such as enrollment, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check100 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision.SummaryDifference3%

Stay in the know with updates to ONC201 + Nivolumab in MSS mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ONC201 + Nivolumab in MSS mCRC Clinical Trial page.